ACBM Acro Biomedical Co., Ltd.
Fundamentals / CIK 0001622996 / USDAcro Biomedical Co., Ltd. reported $0 in revenue and a net loss of $140K for the trailing twelve months ended June 30, 2026.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ACBM in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue TTM$0 Jun 30, 2026
-
Operating Income TTM-$209K Operating profit
-
Net Income TTM-$140K GAAP bottom line
-
Diluted EPS TTM-$0.00 Split-adjusted
-
Free Cash Flow TTM-- Operating CF less CapEx
-
Cash & ST Investments Jun 30, 2026-- Total debt: --
Annual revenue and net income
10 fiscal years (2017 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $658K | $1.20M | $688K | $194K | $1.35M | $8.01M | $510K |
| Cost of Revenue | -- | -- | $0 | $518K | $938K | $529K | $181K | $1.22M | $7.18M | $459K |
| Gross Profit | -- | -- | $0 | $140K | $260K | $159K | $12K | $135K | $833K | $51K |
| Research & Development | -- | $0 | $4.79M | $10.08M | $5.29M | -- | -- | -- | -- | -- |
| Selling, General & Admin | $154K | $38K | $3.52M | $5.93M | $2.67M | $290K | $435K | $577K | $318K | $53K |
| Total Operating Expenses | $154K | $38K | $8.80M | $16.01M | $7.95M | $290K | $435K | $577K | $318K | $53K |
| Operating Income | -$154K | -$38K | -$8.80M | -$15.87M | -$7.69M | -$130K | -$423K | -$442K | $516K | -$2.2K |
| Interest Expense | -- | -- | $3.2K | $1.7K | $893 | $1.1K | -- | -- | -- | -- |
| Income Before Tax | -$101K | -$42K | -$8.81M | -$15.87M | -- | -$136K | -$425K | -$444K | $512K | -$2.2K |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | -$18K | -$53K | -$73K | $92K | $0 |
| Net Income | -$101K | -$42K | -$8.81M | -$15.87M | -$7.70M | -$117K | -$372K | -$371K | $420K | -$2.2K |
| Basic EPS | -- | -- | -- | -- | -$0.14 | $0.00 | -$0.01 | -$0.01 | $0.01 | $0.00 |
| Diluted EPS | $0.00 | $0.00 | -$0.15 | -$0.26 | -- | $0.00 | -$0.01 | -$0.01 | $0.01 | $0.00 |
| Basic Shares Outstanding | -- | -- | -- | -- | -- | 47.8M | 47.8M | 47.8M | 47.7M | 47.2M |
| Diluted Shares Outstanding | 60.0M | 60.0M | 60.0M | 60.0M | 53.8M | 47.8M | 47.8M | 47.8M | 47.7M | 47.2M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Research & Development | -- | -- | -- | -- | -- | -- | $0 | $0 |
| Selling, General & Admin | $18K | $60K | $16K | $115K | $14K | $8.9K | $9.5K | $9.1K |
| Total Operating Expenses | $18K | $60K | $16K | $115K | $14K | $8.9K | $9.5K | $9.1K |
| Operating Income | -$18K | -$60K | -$16K | -$115K | -$14K | -$8.9K | -$9.5K | -$9.1K |
| Interest Expense | -- | -- | -- | -- | -- | $22K | -- | $6.1K |
| Income Before Tax | -- | -- | $43K | -$118K | -$16K | -$10K | -$11K | -$10K |
| Income Tax Expense | -- | -- | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$21K | -$44K | $43K | -$118K | -$16K | -$10K | -$11K | -$10K |
| Diluted EPS | $0.00 | $0.00 | -- | $0.00 | $0.00 | $0.00 | -- | $0.00 |
| Diluted Shares Outstanding | 60.0M | 60.0M | -- | 60.0M | 60.0M | 60.0M | -- | 60.0M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | -- | -- | -- | $5.9K | $95K | $18K | $911 | $1.5K | $1.1K | $37K |
| Cash & Short-Term Investments | -- | -- | -- | $5.9K | $95K | $18K | $911 | $1.5K | $1.1K | $37K |
| Accounts Receivable, Net | -- | -- | $0 | $638K | $598K | $0 | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | $0 | $938K | $879K | $1.06M | $1.15M | -- |
| Total Current Assets | $14K | $5.1K | $1.6K | $658K | $706K | $973K | $879K | $1.07M | $1.48M | $548K |
| Total Non-Current Assets | $0 | $27K | $57K | $30K | $55K | $25K | $53K | $0 | $5.0K | $0 |
| Total Assets | $14K | $32K | $58K | $687K | $761K | $998K | $932K | $1.07M | $1.48M | $548K |
| Accounts Payable | $56K | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Deferred Revenue (Current) | $20K | $20K | $20K | $20K | $20K | -- | -- | $116K | -- | -- |
| Other Current Liabilities | -- | -- | $89K | $79K | -- | -- | -- | -- | -- | -- |
| Total Current Liabilities | $401K | $327K | $289K | $201K | $92K | $312K | $112K | $196K | $241K | $37K |
| Total Non-Current Liabilities | $0 | $0 | $27K | $0 | $26K | $0 | $22K | $0 | $0 | $0 |
| Total Liabilities | $401K | $327K | $315K | $201K | $117K | $312K | $134K | $196K | $241K | $37K |
| Total Debt (incl. Leases) | -- | $27K | $52K | $26K | $50K | $24K | $46K | -- | -- | -- |
| Common Stock | $60K | $60K | $60K | $60K | $60K | $48K | $48K | $48K | $48K | $48K |
| Retained Earnings | -$32.76M | -$32.66M | -$32.62M | -$23.81M | -$7.94M | -$239K | -$121K | -$45K | $325K | -$94K |
| Total Stockholders' Equity | -$387K | -$295K | -$257K | $486K | $644K | $686K | $798K | $874K | $1.24M | $511K |
| Total Equity | -$387K | -$295K | -$257K | $486K | $644K | $686K | $798K | $874K | $1.24M | $511K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | $3.6K | $3.9K | $14K | $4.3K | $40K | $4.9K | $5.1K | $701 |
| Total Non-Current Assets | $0 | $0 | $0 | $0 | $14K | $20K | $27K | $38K |
| Total Assets | $3.6K | $3.9K | $14K | $4.3K | $53K | $25K | $32K | $39K |
| Accounts Payable | $63K | -- | $56K | -- | -- | -- | -- | -- |
| Deferred Revenue (Current) | $0 | $0 | $20K | $20K | $20K | $20K | $20K | $20K |
| Total Current Liabilities | $448K | $431K | $401K | $437K | $371K | $329K | $327K | $317K |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $6.9K |
| Total Liabilities | $448K | $431K | $401K | $437K | $371K | $329K | $327K | $324K |
| Total Debt (incl. Leases) | -- | -- | -- | -- | $14K | $18K | $27K | $33K |
| Common Stock | $60K | $60K | $60K | $60K | $60K | $60K | $60K | $60K |
| Retained Earnings | -$32.82M | -$32.80M | -$32.76M | -$32.80M | -$32.68M | -$32.67M | -$32.66M | -$32.65M |
| Total Stockholders' Equity | -$445K | -$427K | -$387K | -$433K | -$318K | -$304K | -$295K | -$286K |
| Total Equity | -$445K | -$427K | -$387K | -$433K | -$318K | -$304K | -$295K | -$286K |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$101K | -$42K | -$8.81M | $15.87M | -$7.70M | -$117K | -$372K | -$371K | $420K | -$2.2K |
| Stock-Based Compensation | -- | $0 | $8.06M | $15.71M | $7.65M | $0 | $148K | $300K | $7.4K | -- |
| Change in Receivables | -- | $0 | $158K | -$40K | $598K | $0 | -- | -- | -- | -- |
| Change in Inventory | -- | -- | -- | $0 | -$938K | $59K | $181K | $87K | -$666K | -$481K |
| Change in Payables | -- | -- | -- | $50K | $1.5K | $900 | -- | -- | -- | -- |
| Operating Cash Flow | -$196K | -$37K | -$15K | -$147K | $299K | -$199K | -$60K | $80K | -$140K | -$463K |
| Common Stock Issued | -- | -- | -- | -- | -- | -- | -- | -- | -- | $500K |
| Financing Cash Flow | $200K | $37K | $10.0K | $58K | -$222K | $217K | $23K | -$79K | $105K | $498K |
| Net Change in Cash | $3.6K | $100 | -$5.5K | -$89K | $77K | $17K | -$37K | $324 | -$36K | $34K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$21K | -$44K | $43K | -$118K | -$16K | -$10K | -$11K | -$10K |
| Change in Receivables | -- | -- | -- | -- | -- | -- | $0 | $0 |
| Operating Cash Flow | -$11K | -$50K | -$25K | -$54K | -$94K | -$23K | -$11K | -$6.3K |
| Financing Cash Flow | $10K | $50K | $25K | $59K | $94K | $22K | $10K | $6.1K |
| Net Change in Cash | -$225 | -$225 | -$225 | $4.3K | -$225 | -$225 | -$225 | -$225 |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Sep 30 | Sep 30 | Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -- | -- | -- | 21.3% | 21.7% | 23.2% | 6.2% | 10.0% | 10.4% | 10.0% |
| Operating Margin | -- | -- | -- | -2410.0% | -642.5% | -19.0% | -218.4% | -32.6% | 6.4% | -0.4% |
| Net Profit Margin | -- | -- | -- | -2410.2% | -642.8% | -17.1% | -192.0% | -27.4% | 5.2% | -0.4% |
| Return on Equity (ROE) | -- | -- | -- | -3263.2% | -1195.9% | -17.1% | -46.6% | -42.4% | 33.8% | -0.4% |
| Return on Assets (ROA) | -717.4% | -132.3% | -15066.2% | -2308.6% | -1011.4% | -11.8% | -39.9% | -34.7% | 28.3% | -0.4% |
| Current Ratio | 0.04x | 0.02x | 0.01x | 3.27x | 7.71x | 3.12x | 7.88x | 5.46x | 6.14x | 14.83x |
| Quick Ratio | -- | -- | -- | 3.20x | 7.71x | 0.11x | 0.01x | 0.05x | 1.38x | 1.00x |
| Debt to Equity | -- | -- | -- | 0.05x | 0.08x | 0.04x | 0.06x | -- | -- | -- |
| Revenue Growth (YoY) | -- | -- | -100.0% | -45.0% | +74.1% | +255.5% | -- | -83.1% | +1471.5% | -- |
| Gross Profit Growth (YoY) | -- | -- | -100.0% | -45.9% | +62.8% | +1217.8% | -- | -83.8% | +1534.1% | -- |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -185.6% | -- | -105.2% |
| Net Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -188.3% | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -200.0% | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -149.3% | -- | -- | -- | -- | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Return on Assets (ROA) | -3849.0% | -3475.8% | -717.4% | -3570.3% | -87.8% | -164.2% | -132.3% | -128.9% |
| Current Ratio | 0.01x | 0.01x | 0.04x | 0.01x | 0.11x | 0.01x | 0.02x | 0.00x |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -1411.6% |